Ophthalmology

Latest News

FDA Approves Drop for Drug-Induced Dilation of the Pupils
FDA Approves Drop for Drug-Induced Dilation of the Pupils

September 27th 2023

Ryzumi is expected to be available in the first half of 2024. Pricing will be available around the time of launch.

Preservative-free Therapy Launches to Reduce Intraocular Pressure in Glaucoma
Preservative-free Therapy Launches to Reduce Intraocular Pressure in Glaucoma

September 26th 2023

Bausch + Lomb Launches Miebo for Dry Eye Disease
Bausch + Lomb Launches Miebo for Dry Eye Disease

September 12th 2023

FDA Issues CRL for Bevacizumab to Treat Wet AMD
FDA Issues CRL for Bevacizumab to Treat Wet AMD

August 30th 2023

FDA Approves Higher Dose Eylea
FDA Approves Higher Dose Eylea

August 21st 2023

More News

© 2023 MJH Life Sciences

All rights reserved.